SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	3 Months Ended		0 Months Ended
	Mar. 31, 2014	Mar. 31, 2015	Jan. 01, 2014	Feb. 13, 2013	Mar. 07, 2012	Dec. 31, 2014	Nov. 30, 2010
Earnings Per Common Share
Weighted average common stock equivalents from assumed exercise of stock options (in shares)	26,750
Outstanding options included computation of dilutive per-share amounts as effect of all outstanding stock-based awards were antidilutive	189,250
Maximum | Total Sales
Revenue Recognition [Abstract]
Percentage of sales (as a percent)		5.00%
Stock Options
Options
Balance at the beginning of the period(in shares)		181,000
Granted (in shares)	0	0
Expired or forfeited (in shares)		(5,250)
Balance at the end of the period (in shares)		175,750
Exercisable at the end of the period (in shares)		166,836
Weighted-Average Exercise Price Per Share
Outstanding at the beginning of the period (in dollars per share)		6.36
Expired or forfeited (in dollars per share)		7.64
Outstanding at the end of the period (in dollars per share)		6.32
Exercisable at the end of the period (in dollars per share)		6.49
Weighted-Average Remaining Contractual Term
Outstanding at the end of the period		2 years 8 months 19 days
Exercisable at the end of the period		2 years 5 months 9 days
Aggregate Intrinsic Value
Outstanding at the end of the period		46,278
Exercisable at the end of the period		30,856
Additional disclosures
Compensation expense	7,482	3,669
Unrecognized compensation related to unvested awards		13,000
Weighted-average period over which unrecognized compensation costs expected to be recognized		10 months 13 days
Equity Appreciation Rights Plan
Awards exercised (in shares)	0	0
Granted (in shares)	0	0
2010 Plan | Equity Appreciation Rights Plan
Additional disclosures
Compensation expense	43,000	(11,700)
Equity Appreciation Rights Plan
Vesting period from the base date		3 years
Redemption cash payment period		90 days
Shares granted (in units)		100,000	50,000	350,000	250,000
Accrued compensation		201,000				259,000
Accrued compensation included in other accrued liabilities		111,000				47,000
Accrued compensation included in Other Long-Term Liabilities		90,000				$ 212,000
2010 Plan | Equity Appreciation Rights Plan | Maximum
Equity Appreciation Rights Plan
Number of common shares authorized							750,000